Search PubMed⌕ Search

Biomedical subjects

Tetsutaro Sata

Publications and source records attributed to Tetsutaro Sata.

113 records · Page 7Linked to original sources

Molecular characterization of strains of Human herpesvirus 8 from Japan, Argentina and Kuwait.

Current genotyping systems for Human herpesvirus 8 (HHV-8) are based on the highly variable gene encoding the K1 glycoprotein. Most strains collected worldwide cluster into two subtypes (I/A and II/C). Sequenced African strains have belonged to subtypes I/A and IV/B. Members of all three of these subtypes can have either the M or P allele at the right-hand side (RHS) of the genome. Strains obtained predominantly from aboriginal or relatively isolated populations have formed clades that branch at a distance from subtypes I/A and II/C, all being of the RHS P allele. The characterization is reported here of 16 Japanese, two Kuwaiti and five Argentine HHV-8 strains obtained from human immunodeficiency virus-infected and non-infected patients with Kaposi's sarcoma (KS), primary effusion lymphoma, multicentric Castleman's disease or renal transplants. K1 sequences of five Japanese, one Kuwaiti and two Argentine strains were identified as subtype I/A and eight Japanese, one Kuwaiti and three Argentine strains were subtype II/C. Three strains from elderly classic KS patients originally from Hokkaido, a northern Japanese island, were relatively closely related to strains of subtypes III/D and E. Consistent with previous observations, both the M and P alleles were identified at the RHS of subgroup I/A and II/C genomes; only the P allele was detected among the three Hokkaido strains. Distances among the Hokkaido strains were similar to the distance between subtypes I/A and II/C, suggesting that the Hokkaido strains may represent two distinct subtypes and that, as more strains are analysed, the currently recognized III/D subgroups will probably emerge as independent subtypes.

AIDS-Related Opportunistic Infections↗

Human herpesvirus-8 in Kaposi's sarcoma of the conjunctiva in a patient with AIDS.

PURPOSE: To demonstrate human herpesvirus-8 (HHV-8) in Kaposi's sarcoma (KS) of the conjunctiva in a patient with acquired immunodeficiency syndrome (AIDS). METHODS: Clinical observation, pathologic findings of conjunctival specimens, immunohistochemical staining for HHV-8-specific antigen, polymerase chain reaction (PCR) analysis of HHV-8 DNA, and detection of specific antibody in patient's serum at appropriate times. RESULTS: In the conjunctival specimen, swollen endothelial-like cells were found with slit-like vessels. CD 31-positive cells were noted on the inner surface of the slit-like vessels, and HHV-8 latency-associated nuclear antigen was detected. The presence of HHV-8 DNA was demonstrated by PCR. Anti-HHV-8 antibody was found in the patient's serum. CONCLUSIONS: This is the first case report in the ophthalmology literature that provides histological, DNA, and serological evidence that HHV-8 is involved in the pathogenesis of conjunctival KS.

Acquired Immunodeficiency Syndrome↗

Quantitative analyses of cytomegalovirus genome in aqueous humor of patients with cytomegalovirus retinitis.

PURPOSE: To investigate copy numbers of cytomegalovirus (CMV) in CMV retinitis patients during ganciclovir treatment using real-time polymerase chain reaction (PCR). METHODS: Thirteen aqueous humor samples obtained from 6 patients with clinically diagnosed CMV retinitis were analyzed. As controls, aqueous humor samples were obtained at the time of surgery from patients with senile cataracts. RESULTS: The CMV genome was detected in the range from 10(1) to 10(4) copies/microL of aqueous humor before antiviral treatment. The samples obtained from retinitis patients showing widespread retinal changes contained much higher copy numbers than those from patients with focal lesions. After treatment, the copy number decreased to one hundredth of that observed prior to treatment, but the CMV genome was detectable for 4 to 8 weeks after ganciclovir administration to 4 patients. CONCLUSION: These results revealed the correlation between the copy numbers of the CMV genome and the extent of the area affected by CMV retinitis before antiviral treatment, and the prolonged retention of CMV genome after antiviral treatment. Quantitation of the viral genome after the start of therapy will be of value in determining whether to continue or intensify the dosage of antiviral agents.

Adult↗

Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses.

BACKGROUND/AIMS: Oncolytic herpes simplex virus type 1 mutants are promising therapeutic agents for malignant tumors. Their efficacy depends on the extent of both viral replication in the tumor and induction of a host anti-tumor immune response. In this study, new replication-competent, attenuated herpes simplex virus mutants, named HF10 and Hh101, have been evaluated for their oncolytic activities. METHODOLOGY: We determined the genome structures of the mutants and examined the survival rates of mice that were injected intraperitoneally with carcinoma and sarcoma cells and treated with the mutants. Tumors were examined by both histology and immunochemistry. RESULTS: HF10 and Hh101 administration effectively treated disseminated peritoneal colon carcinoma in a BALB/c mouse model and all surviving mice were resistant to rechallenge of the tumor cells. The survival rate in a C3H mouse model was improved by HF10, but not Hh101. CONCLUSIONS: HF10 and Hh101, novel agents as oncolytic viral therapy, are both safe and effective herpes simplex virus mutants for malignant tumor treatment. The Hh101, is more attenuated in its virulence than the HF10 because it is a double gene knocking-out construct. The choice of viral mutant for treatment should be made according to the type of malignancy.

Animals↗